Investigating the prognostic value of KOC (K homology domain containing protein overexpressed in cancer) overexpression after curative intent resection of pancreatic ductal adenocarcinoma

Journal of Gastrointestinal Oncology

H. Lester Kirchner¹  Joseph Blansfield¹  Maged Khalil³  Fan Lin¹  Alva B. Weir III²  Benny Johnson⁴  Shaobo Zhu¹ 

[1] Geisinger Medical Center, Geisinger Health System, Danville, PA, USAGeisinger Medical Center, Geisinger Health System, Danville, PA, USAGeisinger Medical Center, Geisinger Health System, Danville, PA, USA;The University of Tennessee Health Science Center &The University of Tennessee Health Science Center &The University of Tennessee Health Science Center &Lehigh Valley Hospital, The Lehigh Valley Health Network, Allentown, PA, USALehigh Valley Hospital, The Lehigh Valley Health Network, Allentown, PA, USALehigh Valley Hospital, The Lehigh Valley Health Network, Allentown, PA, USA;Department of Medical Oncology, Mayo Clinic, Rochester, MN, USADepartment of Medical Oncology, Mayo Clinic, Rochester, MN, USADepartment of Medical Oncology, Mayo Clinic, Rochester, MN, USA

关键词: Pancreatic ductal adenocarcinoma (PDAC);    biomarker;    KOC/IGF2BP3;    neoadjuvant therapy;   

DOI  :  10.21037/jgo.2016.11.05

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown